MATA NATHAN L. (Chief Scientific Officer) sold 7.9% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $166.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/22/2026ACC: 0001193125-26-170443
Officer· Chief Scientific Officer
Since Mar 2026
-1K
Net shares
Net seller
$166.0K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
1K disposed
Non-Derivative Transactions5
American depositary share
Direct
Shares
−64.00
Price / share
$163.49
Trade value
$10.46K
% of position
0.5%
4/21/2026
12.67K→12.60K
American depositary share
Direct
Shares
−78.00
Price / share
$164.60
Trade value
$12.84K
% of position
0.6%
4/21/2026
12.60K→12.52K
American depositary share
Direct
Shares
−332.00
Price / share
$165.49
Trade value
$54.94K
% of position
2.7%
4/21/2026
12.52K→12.19K
American depositary share
Direct
Shares
−312.00
Price / share
$166.49
Trade value
$51.94K
% of position
2.6%
4/21/2026
12.19K→11.88K
American depositary share
Direct
Shares
−214.00
Price / share
$167.34
Trade value
$35.81K
% of position
1.8%
4/21/2026
11.88K→11.67K
Total
Net shares
−1K
Net value
-$166K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/21/2026 | S · Sale | −64.00 | $163.49 | $10.46K | 0.5% | 12.67K | 12.60K |
| American depositary share Direct | 4/21/2026 | S · Sale | −78.00 | $164.60 | $12.84K | 0.6% | 12.60K | 12.52K |
| American depositary share Direct | 4/21/2026 | S · Sale | −332.00 | $165.49 | $54.94K | 2.7% | 12.52K | 12.19K |
| American depositary share Direct | 4/21/2026 | S · Sale | −312.00 | $166.49 | $51.94K | 2.6% | 12.19K | 11.88K |
| American depositary share Direct | 4/21/2026 | S · Sale | −214.00 | $167.34 | $35.81K | 1.8% | 11.88K | 11.67K |
| Total | −1K | -$166K | ||||||
Derivative Transactions0
No derivative transactions reported